ADMA Price / Book | ADMA BIOLOGICS, INC.

ADMA BIOLOGICS, INC. (ADMA) Price / Book

2026-09-03: Price/Book Ratio 5.26.
2026-06-30: Price/Book Ratio 4.62.
2026-03-31: Price/Book Ratio 5.36.
2025-12-31: Price/Book Ratio 9.09.

Historical market capitalization divided by filed shareholder equity.

Available history: 2013-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	5.26
2026-06-30	4.62
2026-03-31	5.36
2025-12-31	9.09
2025-09-30	8.1
2025-06-30	10.91
2025-03-31	12.67
2024-12-31	11.63
2024-09-30	20.38
2024-06-30	13.84
2024-03-31	9.95
2023-12-31	7.56
2023-09-30	5.34
2023-06-30	5.65
2023-03-31	5.05
2022-12-31	5.66
2022-09-30	4.76
2022-06-30	3.4
2022-03-31	2.83
2021-12-31	1.96
2021-09-30	1.52
2021-06-30	1.89
2021-03-31	1.92
2020-12-31	2.32
2020-09-30	3
2020-06-30	3.29
2020-03-31	2.58
2019-12-31	9.06
2019-09-30	7.31
2019-06-30	4.89
2019-03-31	17.5
2018-12-31	5.6
2018-09-30	7.74
2018-06-30	4.04
2018-03-31	7.34
2017-12-31	2.92
2017-09-30	4.08
2017-06-30	2.3
2016-06-30	19.58
2015-12-31	105.31
2015-09-30	18.22
2015-06-30	10.41
2015-03-31	7.81
2014-12-31	17.27
2014-09-30	10.35
2014-06-30	7.36
2014-03-31	4.88
2013-12-31	3.36

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Vericel Corp (VCEL)	United States	$2.011B	93.97
Greenland Mines Ltd (GRML)	United States	$2.362B
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43